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It has been shown that  strains  of normal cells which  attain relatively low 
population densities in culture (contact inhibition of growth) inhibit each other 
in mixed culture (1). This interstrain inhibition is not species-specific (2). Cul- 
tured  cancer cells,  as well as heteroploid cells which  arise "spontaneously" in 
culture, have in varying degree escaped from contact inhibition of growth, and 
under identical growth conditions attain a higher population density than their 
diploid  counterparts.  Such  heteroploid  cells  are  similarly  insensitive  to  the 
growth inhibitory effects of other cell types, and the degree to which they have 
escaped from growth  inhibition  in  such  mixed  cultures  usually  (but  not  in- 
variably) parallels their maximum growth potential in pure culture (2). 
Most virus-transformed cells resemble natural cancer cells and spontaneous 
heteroploid  transformants in that they have in varying degrees escaped from 
contact inhibition  of growth,  and attain higher population densities than  the 
parent cell; some have an enhanced capacity to form colonies in soft agar (3, 4); 
many are tumorigenic;  and chick embryo cells transformed by Rous sarcoma 
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virus (5),  and mouse 3T3  cells transformed by SV-40 (6),  have been shown to 
have a  decreased serum requirement for growth. 
The present paper describes the degree of correlation between these multiple 
changes in a  number  of human,  monkey, mouse,  and hamster cells transformed 
by  either SV-40,  polyoma,  or  adenovirus. 
Materials  and Methods 
Cell Propagation.--Stock  cultures growing on a  glass surface were subdivided at approxi- 
mately weekly  intervals. The  cultures were  drained,  overlaid for  20-60  sec  in a  minimal 
growth medium (MEM) 1 (7) lacking calcium, magnesium, and serum, but containing 0.25% 
Difco 1:250 trypsin and 0.01% Versene. After standing for 1-4 min, the rounded cells were 
dispersed in growth medium supplemented with nonessential amino acids and  10% serum 
(5% calf serum plus 5% fetal calf serum), and divided 2- to 100-fold,  depending on the growth 
potential of the cell.  Cultures were fed every other day, and on the day before division. In 
the  experiments  to  determine  maximum  population  density  (Table  I),  cultures were  fed 
daily after the 2nd day. 
Cell Strains  Used.--The normal human, monkey, mouse, or rabbit cells used as substrates 
for superinoculation by virus-transformants were all strains which, under the conditions of 
these experiments,  became essentially saturated at  relatively low population densities  (2). 
The vlrus-transformants used in this study are listed in Table I. 
Test for Inhibition  of  Virus-transformants by Normal  Cells. To  determine the degree  to 
which the growth of virus-transformants was  inhibited by contact with normal cells,  fully 
grown  3H-thymidine-labeled cultures of the latter  (0.05 #Ci of  3H-thymidine added  to the 
growth medium for 3-5 days prior to the experiment) were supefinoculated with 14C-thymi- 
dine-labeled virus-transformed cells at 0.3-0.6  )<  104 cells/cm 2. As previously described (2), 
the radioactive labels served to control both the degree  to which the superinoculated cell 
adhered to the cell substrate, and the persistence of both the substrate and superinoculum 
in the following period of incubation. The combined cultures and the controls were fed daily 
with medium supplemented with 5% calf serum  and  5% fetal  calf serum.  The growth of 
the superinoculated cell has been expressed in Table II as a percentage of the growth observed 
in a  control pure culture, calculated as previously described  (2),  and averaging the results 
based  on  cell count and  cell prutein determinations. 
Serum  Requlremenl.--To  determine  the  serum  requirement  of  the  normal  and  virus- 
transformed cells,  cultures were planted in growth medium supplemented either with 2% or 
0.2% serum (half calf and half fetal calf), depending on the serum requirement of the specific 
cell line. 24 hr later, after the cells had adhered to the glass and flattened, they were fed with 
medium containing varying concentrations of serum, refed after 2 days, and daily thereafter. 
The degree of growth was measured both in terms of protein content (9) and cell number, as 
previously described (2). 
Ability of Cells to Grow in Soft Agar.--Log-phase  cultures were dispersed with 0.25% tryp- 
sin, washed with growth medium, counted, and appropriate dilutions inoculated in four repli- 
cate soft agar cultures. Semisolid agar medium (3) was prepared by mixing equal portions of 
1% purified agar  (Difco)  in glass-distilled water and double strength basal medium (BME) 
(10) containing tryptose phosphate broth (20%) and calf serum (20%). A base layer of 7 ml 
was poured into 60 mm Petri dishes and allowed to harden, and then overlaid with 1.5 ml of 
the same medium containing the desired number of cells.  Cultures were incubated at 37°C 
1  Abbreviations used in  lhls paper: ALS,  anti-lymphocyte  serum;  BME,  basal  medium 
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in a humidified atmosphere of 5% CO2 in air, and colonies more than 0.7 mm in diameter were 
counted after 10-20 days. 
Colonies growing in soft agar occasionally were examined for heterogeneity with respect to 
plating efficiency  and heterotransplantability  (see below). Monolayer cultures derived from 
single colonies in soft agar were replated, and the plating efficiency in soft agar determined 
for three successive clones.  Subcultures from the third cloning were reimplanted in the ham- 
ster cheek pouch for comparison with the original culture. No significant differences were seen 
between the parent colonies  and their derived clones,  and they are not distinguished in the 
tables. 
Tumorigenic A ctivity.-- 
Hamster cheek pouch: As originally reported by Patt,  Handler et al.  (11, 12), the cheek 
pouch of the Syrian hamster  (Mesocricetus auratus)  accepts xenogeneic transplants  of some 
neoplastic tissues, but with few exceptions rejects xenogeneic transplants of normal tissue. This 
provided a useful transplantation system for the assay of the "malignant potential" of cultured 
cells (13). The cell lines listed in Table I were implanted into the cheek pouches of Syrian ham- 
sters according to methods described elsewhere  (13). All manipulations were done in complete 
growth medium (BME)  to preserve the physiologic integrity of the cells. Log phase cultures 
of the parent cell lines, or of cultures derived from single colonies, were dispersed with trypsin 
pooled, sedimented at 50-70 g, washed three times with BME, and diluted with BME so that 
the desired inoculum was contained in 0.1 ml of the final suspension.  The total preparation 
time was less than 2 hr, and more than 90-95% of the cells implanted excluded trypan blue. 
Both cheek pouches of each of six hamsters were everted under light Nembutal anesthesia, 
and the inocula were implanted into the connective tissue as an "intracutaneous"  bleb. There 
hamsters  in each group were "conditioned" with cortisone acetate  (saline suspension  ob- 
tained from Merck, Sharp & Dohme, West Point, Pa.), administered subcutaneously in doses 
of 2.5 mg twice weekly. The cheek pouches were observed once or twice weekly for at least 60 
days postimplantation, and evaluated as described elsewhere (13). 
Baby hamster: Since human cancer cells of lymphoid origin can produce tumors in normal 
or anti-lymphocytic serum (ALS)-treated neonatal hamsters (15, 16), the virus-transformants 
were similarly tested. Each animal in two litters of newborn Syrian hamsters (less than 24 hr 
of age, with 8-10 animals per litter) received an intraperitoneal implant of at least 107 packed 
cells in a  volume of 0.1  ml. One litter was treated with ALS administered intraperitoneally 
3 times weekly in doses of 0.05 ml, beginning at the time of implantation. The animals were 
observed for tumor formation and sacrificed  after 60-90 days. 
Mouse inoculation: Swiss female mice, 8-10 wk of age, were injected subcutaneously into 
the flank with cells prepared as for hamster cheek pouch inoculation. Mice were observed for 
tumor formation twice weekly for 9 months. In addition, newborn mice were injected intra- 
cerebrally with 0.01 ml of a similar cell suspension,  and observed for signs of cerebral involve- 
ment. When mice died after inoculation, brain tissue was examined histologically for presence 
of tumor tissue; and survivors were sacrificed for similar examination after 2 months. 
RESULTS 
Growth Capacity  of Virus-Tranfformants.--As  seen  in  the  last  two  columns 
of Table I  and in Fig.  1,  although  transformation  by viruses usually caused  a 
significant increase in the maximum  cell population  achieved under  the condi- 
tions of the present experiments,  the magnitude of that increase varied widely. 
Marked  increases  were observed in  six different lines after  SV-40  transforma- 
tion;  but  an  adenovirus-transformed  monkey  cell  showed  only  slightly  en- 866  GROWTH  CHARACTERISTICS  OF  VIRUS-TRANSFORMeD  CELLS 
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hanced growth capacity. A monkey cell transformed by an adeno-SV-40 hybrid 
showed the small increase in maximum population density seen in the adeno- 
virus transformant,  rather than the marked increase  caused by SV-40 trans- 
formation alone.  Finally,  although  the polyoma-transformed hamster kidney 
cell attained an extremely high population density, the growth capacity of that 
virus-transformant was  no  greater  than  that  of  a  cell  (BHK-E)  which  had 
transformed "spontaneously" in culture. 
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Fro. 1. The effect of virus transformation on the maximum population density achieved 
under standardized conditions of growth. (For human cell controls, see footnote :~, Table I). 
It is of interest that the virus-transformed cells were usually smaller than the 
parent  cells.  The  increase  in  cell  population  effected  by  transformation  of 
human, monkey, and mouse cells regularly exceeded the increase in cell protein, 
the amount of protein per cell in the transformants varying between 48-77 % 
of that of the parent cell (cf. last two columns of Table I). 
Susceptibility  of  Virus-transformed  Cells  to  Growth  Inhibition  by  Normal 
Cells.--With a wide spectrum of normal and cancer cells, it had been found (2) 
that  when  small  numbers  of  cells  were  superinoculated  onto  an  essentially 
saturated monolayer of human or mouse cells, the ability of the superinoculated 868  GROWTH  CHARACTERISTICS  OF  VIRUS-TR,42qSFORMED  CELLS 
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cell to grow was usually correlated with its inherent capacity for growth: the 
higher the population density attained by a given cell type in pure culture, the 
less was its susceptibility to inhibition by other cell types. When virus-trans- 
formed cells were similarly superinoculated, the results were extremely variable 
(Table II), and there was no such clear relationship between growth capacity 
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Fro. 2. Growth of virus-transformed  cells when superinoculated  onto essentially  saturated 
monolayers  of human diploid  fibroblasts. Human cells  transformed by SV-40, ~; monkey  cells 
transformed by SV40 []; by adeno, 17; by adeno-SV-40, Irl; mouse cells transformed by 
SV-40~, ; hamster cells transformed by polyoma,  V&. 
and susceptibility to inhibition (Fig. 2).  Some of the virus-transformants, in- 
cluding a few with a  high capacity for growth, were markedly inhibited  (cf. 
inhibition  of  SV-40-transformed mouse  and  human  cells by human  diploid 
fibroblasts (v  ~  and  ~  in Fig. 2), of GMK-EVa and W  18-Va  by mouse fibro- 
blasts (Table II), and of GMK-adeno by both the parent cell and by rabbit lens 
cells).  At  the  other  extreme, some virus-transformants,  like most  naturally 
occurring cancer cells (2), were not  appreciably inhibited by contact with  a 
saturated cell substrate (cf. polyoma-transformed BHK cell overlaid onto any 
other cell type: last column of Table II, and v  & in Fig. 2). In most of the other 870  GROWTH  CHARACTERISTICS  OF  VIRUS-TRANSFORMED  CELLS 
cell combinations, the transformants were partially but significantly inhibited, 
although the results in repeat experiments sometimes varied widely (cf. Table 
II). As with the normal and cancer cells previously studied (2),  the intercell 
inhibitions observed were not species-specific. 
The varying susceptibility of virus-transformants to inhibition by contact 
with normal ceils, and the variability in the results obtained in replicate experi- 
ments with the same cell lines (Table II) are consistent with the widely vary- 
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ing results previously reported, ranging from marked inhibition of growth (17- 
19) to essentially total escape from inhibition (20, 21). 
The Serum Requirement of Normal  and  Virus-Transformed  Cells.--In  con- 
firmation of the results of Temin (5)  with chick embryo cells transformed by 
Rous virus, and of Holley (6) with the mouse 3T3 and its SV-40 transformant, 
significantly lower  concentrations of serum  were  required for  the  sustained 
growth of most virus-transformants than for the parent cells. Although both cell 
types grew at essentially the same rate in high concentrations of serum (20 %), 
the  virus-transformants  generally  attained  higher  population  densities.  A 
typical experiment is shown in Fig. 3. 
Fig. 4 contrasts the effect of serum concentration on the population density 
achieved by a number of normal and SV-40-transformed human cells; and Fig. 
5  similarly contrasts  the difference in their response to serum, measured in EAGLE,  FOLEY~ KOPROWSKI,  LAZARUS, LEVINE~ AND  ADAMS  871 
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by the average doubling time for cell protein during the logarithmic phase of growth.  (For 
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terms  of doubling  time for cell protein  in log phase.  Not  all  the  virus-trans- 
formants,  however,  showed  as  striking  an  effect  as  the  SV-40-transformed 
human lines.  In Table III, the serum response of the virus-transformants  has 
been  expressed  as  the  concentration  which  permits  protein  synthesis  in  log 
phase at half the rate observed in 20% serum.  As there seen,  neither  the SV- 
transformed  mouse  fibroblast  nor  the  polyoma-transformed  hamster  kidney 
cell differed significantly from the parent with respect  to their serum require- 
TABLE III 
Concentration of Serum  which Permits Cell Multiplication*  at 50~o of the Rate 
Observed in 20% Serum 
Species 
Human 
Monkey 
Mouse 
Hamster 
~c 
Cel[ strain 
MS 2 
Penny 
Wi 38 
Det 
GMK 
c~ 
3T3 
BHK 21 
Virus 
SV-40 
c~ 
Adeno 
SV-40 
Adeno-SV40 
hybNd 
SV-40 
Polyoma 
Spontaneous 
transformant 
Transformant~ 
98H 
18Va 
26Va 
GMK-adeno 
EVa 
LL 
SV-3T3 
"50% effective" serum 
concentration 
Normal 
10 
3, 1-2 
1,  1 
1.7 
1, 24- 
2, 2, 3.4 
Virus transformant:~ 
0.1, <0.1 
1 
<0.2,  <0.05, 
0.4, <0.1 
0.8, 0.5 
0.5, 0.6 
<0.2,  <0.2 
2.5 
1.5 
1-2 
* Based on time required for doubling of cell protein in logarithmic phase of growth under 
conditions of present experiments. 
See footnote:~, Table I. 
ment.  In both cases,  however,  the parent  cell used for comparison was a  line 
which had transformed "spontaneously" in culture and had developed at least 
some of the properties of virus-transformants.  Subcultures of the same line ob- 
tained  from  other  laboratories  had  significantly  higher  serum  requirements 
than that here studied.  The monkey kidney adeno- and  SV-40-transformants 
showed a small but significant decrease in serum requirement; and that require- 
ment was greatly reduced in the cell transformed  by the hybrid SV-40-adeno- 
virus. 
Colony Formation in Soft Agar.--It has been found in a number of laboratories EAGLE,  FOLEY,  KOPROWSKI,  LAZARUS,  LEVINE,  AND  ADAMS  873 
(4) that virus-transformation often results in increased plating efficiency in soft 
agar. With the virus-transformants here studied, the number of colonies formed 
per  105 cells varied  widely,  from zero in  the  case  of the  GMK-adeno-trans- 
formant to  1565 for the hamster polyoma-transformant  (Table  IV).  Surpris- 
ingly, two sublines of the same hamster kidney culture (cf. Table I, footnotell), 
both  of which were tumorigenic,  gave wholly disparate  results  on inoculation 
into soft agar. One yielded an average of 690 colonies per 105 cells inoculated, 
TABLE IV 
Plating Efici~ ~  Virus-Tranfformantsin SoflAgar 
Species 
Human 
Mouse 
Cell 
Monkey 
Hamster 
Transforming virus 
None 
SV-40 
None 
SV--40 
None 
SV-40 
Adeno 7 
Adeno 7-SV 40 
None (spon- 
taneous trans- 
formant) 
Polyoma 
Strain designation 
Variety of human 
diploid fibro- 
blasts 
W-98-Va-E 
W-98-Va-H 
W-18-Va2 
Wi-26-Va4 
3T3 
3T3  -SV40 
AGMK 
AGMK-EVa 
AGMK-adeno 
AGMK-LLE46 
BHK-21 
BHK-21-E 
BHK-PY 
Cell inoc- 
ula X 104 
--100 
2.5-10 
0.5-8 
D. 125--4 
5-20 
10-1~ 
2.5-10 
6.75-100 
~.625-10 
5-1~ 
5-40 
5-100 
3.675-1.25 
0.25-2 
Plating efficiency 
(colonies/105 ceils) 
Range  Mean 
<0.1  0 
40--44  42 
80-153  111 
165-240  191 
10-12  11 
1.8-2.  2 
28-30  29 
<0.1  0 
302-432  363  .o  o 
13  5-20  15.7 
<0.1!  <0.1! 
550-770!  690! 
480-1520 1540 
and the other gave none with 106 cells. Except for the mouse 3T3 cell, none of 
the normal cells tested produced colonies, even with inocula of 106 cells. 
Tumorigenic Activity.- 
Hamster cheek pouch: As indicated in the first two columns of Table V, of the 
nine virus-transformed  cell lines here  studied,  0nly the polyoma-transformed 
hamster kidney cell (3) was tumorigenic when implanted in the cheek pouch of 
the  Syrian  hamster.  In  this  case,  however,  the  parent  culture  was  just  as 
tumorigenic as the virus transformant. The two sublines of the parent cell used 
in these experiments, both of which had transformed spontaneously in terms of 874  GROWTH  CHARACTERISTICS  OF  VIRUS-TRANSFORMED  CELLS 
maximum population density and  escape from  contact inhibition by normal 
cells, were equally tumorigenic, despite the fact that one of these sublines did 
not grow in soft agar. 
Baby hamsters and mice:  Similar results were obtained when the virus-trans- 
TABLE  V 
Degree of Correlation in the Altered Properties of  Viral Transformants* 
Viral transformant 
Human 
Monkey 
Mouse 
Hamster 
kidney 
SV-40 
Adeno 
SV 40-adeuo 
hybrid 
SV-40 
Polyoma 
98E 
H 
18Va 
26Va 
GMK-EVa 
GMK-adeno 
AGMK-LL- 
E46 
SV-3T3 
BHK-21-Py 
to produce 
In 
hamster 
cheek 
pouch 
.....  tumor~t  Escape from contact  inhibition 
Increased 
population 
density  Susceptibility  to 
under stand-  inhibition  by 
In  ardized  normal  cell mono- 
mouse  conditions  layers  (Table II) 
-  of growth 
] ~raln I  (Table I) 
Cell  key  o  1~  a-  e=  Pro-  Hu-  [ol 
tein  man 
o*  --  --  ++ 
o  o  + 
o  --  ++ 
o  o  +++ 
o  o  +++ 
o  ++ 
o  o  + 
o  o  o  ++ 
+(105)§  +(105)  o 
f++] +0 
~+ I++ 
4-  H-+ 
+  I  + 
+++ ++÷  +  +- 
--  ±  0  0 
Greater 
P~i2g 
ciency 
in soft 
agar 
Gable 
IV) 
+ 
b  ++ 
++ 
+  + 
++ 
0 
+ 
-Jl  +++ 
* +, ++,  +++  reflect the following arbitrary weighing of data in Tables  I-IV: 
0  :e  +  ++  +++ 
Growth rclative to control  (Table I)  > 1-2  > 2-4  >4- 
Growth  inhibition  by  other  cells  >60  >40-60  >20--40  >10-20  >10 
(Table II) 
Serum requirement  for 50~  growth  =>1%  >0.2-1.0  >0.05-0.2  ->0.05 
(Table III) 
Colonies/105 ceils in soft agar (Table  0  1-100  > 100-1000  > 1000 
IV) 
;~ 0, no tumor produced by 10  s cells 
§ +, tumor produced by 10  ~ cells, but not at lower doses. In this  case, however, cultures  of 
the parent cell were also tumorigenic, and in both the hamster cheek pouch and baby hamster. 
]] Parent (untransformed) culture not available for study. 
formants  were  inoculated  intraperitoneally  into  neonatal  hamsters.  The 
polyoma-transformed hamster kidney cell (BHK-21) was tumorigenic, as were 
"control" sublines of the parent cell, but none of the other virus-transformants 
studied produced tumors even with inocula of 106 cells (Table V). Neither the EAGLE, ]~OLEY, KOPROWSKI~  LAZARUS, LEVINE,  AND AD/k~S  875 
parent BHK nor its polyoma-transformant produced tumors in newborn mice 
injected intracerebrally. 
DISCUSSION 
i 
Virus-transformation effects a number of major changes in cell properties, in 
addition to the acquired oncogenicity (22); and a  similar pattern  of  change is 
seen in cancer cells and in spontaneous transformants in vitro (22), as well as in 
cells transformed by X-ray (23)  or by carcinogens (24). The degree of associa- 
tion  among the  five such properties  studied  in  the  present  experiments  with 
eight virus-transformants  is indicated  in Table V.  Except for tumorigenicity, 
all the virus-transformed lines were altered with respect to most of the proper- 
ties studied.  That  association was, however, not invariable;  and there was no 
clear correlation in the magnitude of the changes observed. Thus,  the hybrid 
SV-40-adenovirus-transformant  of  the  monkey kidney  line  grew  to  smaller 
population densities than either of the individual transformants  (Table I), but 
had a  lower serum requirement  than  either  (Table II), and was intermediate 
with respect to its capacity to grow in soft agar (Table IV). 
The most prominent  characteristic  of the virus-transformants  here studied 
was the failure of all but one (the polyoma-transformed baby hamster kidney 
cell) 2 to  produce  tumors  on  inoculation  either  into  the  cheek  pouch  of  the 
hamster, into neonatal hamsters, or into the mouse brain. This may mean only 
that a negative result in these specific systems does not exclude "malignancy" 
(i.e. the ability of the transformed cell to produce a cancer) under other condi- 
tions.  The  fact  that  the  transformed  cells  failed  to  produce  tumors  in  the 
hamster cheek pouch or peritoneal cavity even when the immunologic mecha- 
nisms  of the host had been depressed  by treatment  with  cortisone acetate  or 
anti-lymphocytic serum,  respectively,  does not wholly exclude the possibility 
that  the  generally negative  results  reflect heterospecific rejection  of a  poten- 
tially tumorigenic cell. 3 Alternatively, however, the cells may never have been 
malignant,  or if tumorigenic when first transformed, had lost that property in 
the  course of their  serial  propagation,  as has been shown to occur with both 
naturally occurring cancer cells (25) and virus-transformants  (26, 30). 
2 It is of interest  that the two sublines of the BHK (hamster kidney) cell used as controls 
for the polyoma transforraant  were just as tumorigenic as the virus transformant.  The possi- 
bility that these spontaneous variants may have been transformed  by an unrecognized virus 
can of course not be excluded. The presence of virus-like particles  in clones of this  strain 
has in fact been reported  from  two laboratories  (28, 29). 
3 It has in fact recently been found (Dr. E. Stanbridge and Dr. F. Perkins, personal com- 
munication) that an SV40-transformed  human line produced "tumor nodules" when inocu- 
lated  subcutaneously  into mice treated  with  anti-lymphocytic  serum;  and  Dr.  B.  Pessac 
(personal communication) has similarly found that mice treated  with X-ray postnataUy de- 
veloped tumor nodules after subcutaneous inoculation with either the parent or SV-40-trans- 
formed 3T3 lines. Those tumors, however, regressed unless the mice were treated  with  anti- 
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Be that as it may, it is apparent that an enhanced capacity for growth, rela- 
tive insusceptibility to inhibition by contact with normal cells, decreased serum 
requirement,  and  enhanced  capacity to grow in soft agar,  did not in  and  of 
themselves endow the cells here studied with the ability to produce a tumor in 
hamsters or mice. Along  the same lines,  Rabson  et al.  (31)  have found that 
SV-40-transformed monkey cells were not tumorigenic on autologous inocula- 
tion,  and widely varying results have been obtained  with  cloned  sublines of 
polyoma-transformed  Chinese  hamster  cells  (30).  Further,  McAllister  and 
Reed. (32)  have pointed out that normal and cancerous human cells cannot be 
distinguished on the basis of their capacity to grow in soft agar. In the present 
experiments  also,  a  number  of virus-transformants  which  grew  in  soft  agar 
failed to produce tumors on inoculation;  and conversely, although  two spon- 
taneous transformants of a hamster kidney line were just as malignant as the 
virus-transformant, as judged by animal inoculation, one failed to form colonies 
in soft agar even with inocula of l0 G  cells (Table IV). The dissociation between 
the tumorigenicity of virus-transformants and many of the other altered proper- 
ties is further evidenced by the fact that at least some of these alterations may 
develop before the transformants become capable of producing a  tumor (21). 
Conversely,  revertants  of polyoma-transformed hamster  cells  have been  de- 
scribed which retain the capacity to produce a  tumor although they have re- 
verted toward normal with respect to most of the other changes associated with 
viral transformation (27). The possibility of course remains that altered proper- 
ties of virus transformants other than those here studied  (e.g. a new antigenic 
activity, or a specific chemical change in a cell glycolipid) (36)  may be the im- 
mediate determinants of their oncogenicity. 
Despite the evidence that the phenotypic consequences of viral transforma- 
tion here studied are neither a necessary nor sufficient condition for the ability 
of the transformed cells to produce a  tumor in experimental animals, the fact 
remains that these alterations and tumorigenicity are conjoined with high fre- 
quency, not only in virus-transformants, but in spontaneous transformants and 
naturally occurring cancer cells as well.  Further, it has been shown by two dif- 
ferent procedures that mouse cells selected simply on the basis of their increased 
susceptibility  to contact  inhibition  of growth  also  showed  decreased  tumori- 
genicity  (33,  34).  Similarly, revertants  of polyoma-transformed hamster  (26) 
and  mouse  cells  (31)  have  been  described  which  had  lost  their  capacity  to 
produce a  tumor and had simultaneously reverted toward normal in terms of 
saturation  density,  susceptibility to contact inhibition,  and inability to clone 
in soft agar. 
As  already indicated,  the  fact  that  the  phenotypic  changes  seen in  virus 
transformants  are not  invariably associated with  tumorigenicity may reflect 
only the inadequacy  of any of the presently available animal tests of malig- 
nancy. Alternatively, however, the determinants of malignancy may be closely EAGLE, FOLEY, KOPROWSKI, LAZARUS, LEVINE, AND  ADAMS  877 
linked  to,  rather  than  identical  with,  those  of the  other properties of virus- 
transformed cells here studied. In any case, as previously suggested by Federoff 
(35)  and others, there as yet appea:r to be no generally valid in vitro criteria for 
predicting tumorigenicity. 
SUMMARY 
Virus  transformants  (like  cancer cells,  cells  transformed by X-ray or  car- 
cinogens, or those which have transformed spontaneously) exhibit a number of 
phenotypic changes which are usually associated, and which may be lost con- 
currently. That association is, however, not invariable. More particularly  , the 
altered characteristics here studied  (escape from contact inhibition  of growth 
and  susceptibility to inhibition  by other  cells,  decreased serum requirement, 
and ability to grow in soft agar) do not, in and of themselves, endow the cell 
with the capacity to produce a  tumor,  at least as judged by the methods of 
assay here used.  Although  the  question  as to whether  the  tumorigenicity of 
virus transformants is causally linked to any of these associated changes cannot 
be  answered  definitively,  the  evidence suggests a  close  linkage,  rather  than 
identity,  between  the  determinarLts of oncogenicity and  the  other properties 
here studied. 
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